Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer

Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer

Background: To evaluate the efficacy of intravesical chemotherapy replacement in patients with intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC), who underwent bacillus Calmette-Guérin (BCG) instillation but discontinued due to global shortages or toxicity of BCG. Methods: This...

Full description

Bibliographic Details
Main Authors: Po-Ting Lin, Wei-Kang Hung, Ying-Hsu Chang, Ming-Li Hsieh, Chung-Yi Liu, Liang-Kang Huang, Yuan-Cheng Chu, Hung-Cheng Kan, Po-Hung Lin, Kai-Jie Yu, Cheng-Keng Chuang, Chun-Te Wu, See-Tong Pang, I-Hung Shao
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
bladder cancer
intravesical instillation
NMIBC
BCG
bladder recurrence
Online Access:https://www.mdpi.com/2072-6694/15/4/1345

Internet

https://www.mdpi.com/2072-6694/15/4/1345

Similar Items